Form 4: Twist Bioscience SVP Sells Shares to Cover Tax Obligations Following RSU Vesting

Paula Green, Senior Vice President of Human Resources at Twist Bioscience Corp., executed a non-discretionary sale of 292 common stock shares to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Summary

• Paula Green, SVP of Human Resources at Twist Bioscience Corp. (TWST), reported a transaction on June 20, 2025.
• The transaction involved the sale of 292 shares of common stock at a price of $35.755 per share.
• This sale was a 'sell to cover' transaction, mandated by the Issuer's equity incentive plans to satisfy tax withholding obligations upon the vesting of Restricted Stock Units.
• The sale was not a discretionary trade by Ms. Green.
• Following this transaction, Ms. Green beneficially owns 127,603 shares of Twist Bioscience common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral. This is a routine, non-discretionary transaction for tax purposes related to RSU vesting, which is a common occurrence for executives receiving equity compensation. It does not indicate any change in company fundamentals or insider sentiment.

Positives

• The transaction indicates the vesting of Restricted Stock Units (RSUs) for the SVP of Human Resources, which is a positive event for the employee as it represents earned compensation.
• The 'sell to cover' mechanism is a standard and expected procedure for managing tax liabilities associated with equity compensation, demonstrating adherence to company policy.

Negatives

• The sale of shares, while non-discretionary, reduces the insider's direct ownership slightly, though this is a routine tax event rather than a reflection of negative sentiment.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The sale of 292 shares was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and does not represent a discretionary trade by the Reporting Person.

Industry Context

This transaction is a routine insider filing common across all industries, including biotechnology, where equity compensation like Restricted Stock Units (RSUs) is a standard component of executive compensation packages. It does not reflect specific industry trends but rather standard corporate compensation and tax practices.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a small, non-discretionary sale for tax purposes and does not signal a change in insider confidence or company fundamentals.
• Employees: No direct impact beyond the reporting person, though it highlights the company's equity compensation practices.

Key Dates

Keywords

Twist Bioscience, TWST, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Sell to Cover, Tax Withholding, Equity Compensation, Biotechnology, Genomics